Geron is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.Read more
Celgene is the biggest rival of Geron Corp. Celgene was founded in 1986, and its headquarters is in Summit, New Jersey. Celgene operates in the Biotechnology industry. Celgene has 8,835 more employees than Geron Corp.
Otsuka has been one of Geron Corp's top competitors. Otsuka is a Public company that was founded in Chiyoda-ku, Tōkyō Prefecture in 2008. Otsuka is in the Pharmaceuticals industry. Otsuka has 32,975 more employees vs. Geron Corp.
$ < 1M
Geron Corp's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 2.2B. Over the last four quarters, Geron Corp's revenue has grown by 218.6%. Specifically, in Q1 2021's revenue was $ < 1M; in Q4 2020, it was $ < 1M; in Q3 2020, it was $ < 1M; in Q2 2020, Geron Corp's revenue was $ < 1M.
No recent acquisitions found related to Geron Corp
No recent investments found related to Geron Corp